)
Visual21 Nov 2025
Data center suppliers
VolitionRX (VNRX) investor relations material
VolitionRX Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary14 Nov, 2025
Executive summary
Transitioned from R&D to commercialization, focusing on epigenetic blood tests for early disease detection, especially cancer and sepsis, with the Nu.Q platform advancing in both human and veterinary diagnostics.
Signed major agreements with Werfen for APS and Hologic for Nu.Q Discover, expanding global reach and engagement in both human and veterinary markets.
Engaged in discussions with about 10 leading diagnostic and liquid biopsy companies for potential licensing deals.
Recent launches and agreements include new markets for Nu.Q Vet Cancer Test and research collaborations with major diagnostics companies.
Capture-Seq technology submitted for peer review, demonstrating 100% sensitivity and specificity in a small cancer patient sample.
Financial highlights
Q3 2025 revenue grew 32% year-over-year to $0.6 million; nine-month revenue was $1.3 million, up from $1.0 million year-over-year.
Operating expenses decreased 10% year-over-year for the quarter and 18% for the first three quarters, mainly due to lower personnel and R&D costs.
Net loss improved by 8% for the quarter and 20% for the first three quarters; net loss for nine months was $17.2 million, down from $21.4 million.
Net cash used in operations decreased 33% year-over-year to $3.6 million for the quarter.
Cash and cash equivalents at September 30, 2025, were $0.2 million, with an accumulated deficit of $246.6 million.
Outlook and guidance
No revenue guidance provided due to early commercialization and revenue lumpiness; management expects continued losses as commercialization and product development continue.
Focus remains on executing additional licensing agreements in human diagnostics and securing milestone payments in veterinary products.
Plans to secure additional capital through licensing, equity, debt, and grants; cost controls and cash preservation measures are ongoing.
Anticipates transformative quarters ahead with more deals and peer-reviewed publications expected.
Substantial doubt remains about the ability to continue as a going concern without further financing.
Capture-Seq licensing deal timing
What defines a significant licensing deal?
Nu.Q Vet wellness panel adoption timeline?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next VolitionRX earnings date
Q4 202527 Mar, 2026
Next VolitionRX earnings date
Q4 202527 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
VolitionRX Ltd is a multi-national epigenetics company that specializes in the development of blood tests through its proprietary Nucleosomics™ platform. This platform is designed to create simple, easy-to-use, and cost-effective blood tests aimed at diagnosing and monitoring a variety of life-altering diseases, including some cancers and diseases related to NETosis, such as sepsis and COVID-19. The company is headquartered in Henderson, Nevada, and its shares are listed on the NYSE American under the ticker symbol VNRX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage